ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2021 Financial Results on March 15, 2022

Rhea-AI Summary

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is set to release its fourth quarter and full year 2021 financial results on March 15, 2022, at 8:30 a.m. ET. The conference call will be hosted by CEO Nikhil Lalwani and CFO Stephen P. Carey. Investors can access the live and replay webcast on the company's website under the “Investors” section. ANI Pharmaceuticals focuses on developing high-quality branded and generic prescription drugs, aiming for sustainable growth through a strong Purified Cortrophin^™ Gel franchise and enhanced generics.

Positive

• Announcement of fourth quarter and full year 2021 financial results, which may provide insights into company performance.
• Focus on sustainable growth through Purified Cortrophin^™ Gel franchise and enhanced generics.

Negative

• None.

BAUDETTE, Minn.--(BUSINESS WIRE)--

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its fourth quarter and full year 2021 financial results on Tuesday, March 15, 2022.

Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, will host a conference call to discuss the results as follows:

Date			Tuesday, March 15, 2022
Time			8:30 a.m. ET
Toll free (U.S.)			888-269-5332
Webcast (live and replay)			www.anipharmaceuticals.com, under the “Investors” section

A replay of the conference call will be available within two hours of the call’s completion and will remain accessible for two weeks by dialing 866-518-6930 and entering access code 8402712.

About ANI

ANI Pharmaceuticals is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin^™ Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit www.anipharmaceuticals.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220307005357/en/

Investor Relations:

Lisa M. Wilson, In-Site Communications, Inc.

212-452-2793

lwilson@insitecony.com

Media:

Angela Salerno-Robin

dna Communications

212-445-8219

ASalerno-Robin@dna-comms.com

Source: ANI Pharmaceuticals, Inc.

FAQ

When will ANI Pharmaceuticals release its Q4 and full year 2021 financial results?

ANI Pharmaceuticals will release its Q4 and full year 2021 financial results on March 15, 2022.

What time is the ANI Pharmaceuticals conference call for financial results?

The ANI Pharmaceuticals conference call for financial results is scheduled for 8:30 a.m. ET on March 15, 2022.

How can I access the ANI Pharmaceuticals financial results conference call?

The conference call can be accessed via phone at 888-269-5332 or through the live and replay webcast on ANI's website.

Who will host the ANI Pharmaceuticals financial results conference call?

The conference call will be hosted by CEO Nikhil Lalwani and CFO Stephen P. Carey.

What is the primary focus of ANI Pharmaceuticals?

ANI Pharmaceuticals focuses on developing, manufacturing, and marketing high-quality branded and generic prescription pharmaceutical products.